Germany· DE-A57-5fd1f20cdd03bbbd
Nitrendipin-Ratiopharm
A nitrendipine product containing nitrendipine, registered in Germany by Ratiopharm Gmbh. The same ATC class is registered in 6 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Nitrendipine is registered in 6 of 19 countries.
Countries holding a registration under ATC C08CA08 (nitrendipine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Nitrendipine · ATC C08CA08
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Polandprice
- Spainprice
Price per daily dose
What a daily dose of nitrendipine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nitrendipine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- FR France$0.37
- ES Spain$0.36
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Nitrendipine
- Manufacturer
- Ratiopharm Gmbh
- Country
- Germany (DE)
- ATC code
- C08CA08
- ATC class
- Nitrendipine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for nitrendipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitrendipine · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Nitrendipine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLUSOPRESSIstituto Luso Farmaco d´Italia S.p.A., Milano
- PolandNitrendypina EgisEgis Pharmaceuticals PLC
- BelgiumBaypress 20, 20 mgBayer
- FranceNITRENDIPINE VIATRIS 10 mg, compriméVIATRIS SANTE
- SpainNITRENDIPINO STADA 20 mg COMPRIMIDOS EFGLaboratorio Stada S.L.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Czechia · Lusopress, Nitrendipin Ratiopharm
- Estonia · Lusopress, Nitresan
- France · Nitrendipine Viatris
- Greece · Lisba, Nelconil
- Italy · Lusopress
- Lithuania · Lusopress, Nitresan
- Latvia · Lusopress, Nitresan
- Poland · Nitrendypina Egis, Nitresan
- Portugal · Hiperdipina
- Slovakia · Lusopress, Nitresan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/caf4f266-33eb-4c8b-911b-c3704b1c7065 GET /v1/drugs/caf4f266-33eb-4c8b-911b-c3704b1c7065?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Nitrendipine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about nitrendipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.